Literature DB >> 6985855

Valproate plasma protein binding in the uremic condition.

D Brewster, N C Muir.   

Abstract

The protein binding of sodium [carboxy-14C] valproate has been studied in normal and uremic plasma using the method of equilibrium dialysis. Protein binding was dependent on concentration in both cases but there was a marked reduction in binding capacity in patients with renal dysfunction. Treatment of normal plasma with urea or creatinine to reproduce concentrations observed in uremia induced small decreases in binding. Diffusion dialysis of uremic plasma partially restored the degree of binding. Pretreatment of uremic plasma with activated charcoal at pH 3 raised binding capacity to that of normal plasma.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6985855     DOI: 10.1038/clpt.1980.12

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  6 in total

Review 1.  Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

Authors:  R Zini; P Riant; J Barré; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

2.  Case files of the Children's Hospital of Michigan Regional Poison Control Center: the use of carnitine for the management of acute valproic acid toxicity.

Authors:  Abhishek Katiyar; Cynthia Aaron
Journal:  J Med Toxicol       Date:  2007-09

3.  Alteration of drug-protein binding in renal disease.

Authors:  M M Reidenberg; D E Drayer
Journal:  Clin Pharmacokinet       Date:  1984-01       Impact factor: 6.447

4.  Pharmacokinetics of intravenous and oral tolmesoxide.

Authors:  J G Lloyd-Jones; R Henson; J D Nichols; D Greenslade; J M Clifford
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

5.  Distribution of sodium valproate in normal whole blood and in blood from patients with renal or hepatic disease.

Authors:  R J Shirkey; L B Jellett; D C Kappatos; T J Maling; A Macdonald
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  The effects of peritoneal dialysis on the single dose and steady state pharmacokinetics of valproic acid in a uremic epileptic child.

Authors:  J M Orr; K Farrell; F S Abbott; S Ferguson; W J Godolphin
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.